Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the existence of gene mutations based on images of leukemia cells. To solve ...
Retrospective evaluation of an AI-based fusion prioritization agent for oncogenicity assessment in clinical sequencing. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Researchers have developed the first computer machine-learning model to accurately predict which patients diagnosed with acute myelogenous leukemia, or AML, will go into remission following treatment ...